| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b78d171e9237a9885e91b7f4f696d38b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
1991-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc30e45cd74d5c515d1301f59d74fdca |
| publicationDate |
1992-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9200990-A1 |
| titleOfInvention |
Interleukin receptor expression inhibiting antisense oligonucleotides |
| abstract |
Disclosed are oligonucleotide compounds that inhibit interleukin receptor expression when administered to a human subject. Also disclosed are pharmaceutical compositions and methods for inhibiting human interleukin receptor expression. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0928419-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0928419-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5834440-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9503788-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9524202-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5668006-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0578962-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0578962-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-677417-B2 |
| priorityDate |
1990-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |